Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUPERDRY PLC Remuneration Information 2018

Jul 30, 2018

5316_dirs_2018-07-30_de73bc18-dc13-4716-ab8d-80353e4bc6a2.html

Remuneration Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2075W

Superdry PLC

30 July 2018

SuperdryPlc

("Superdry") ("the Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")

Superdry Performance Share Plan ("PSP"): Grant of 2018 Conditional Share Awards

On 25 July 2018, the PDMRs named below were granted conditional share awards over Ordinary Shares under the terms of the Superdry 2018 Performance Share Plan ("PSP"). Details of the number of Ordinary Shares subject to such awards are set out in the table immediately below.

Name / Position of PDMR Number of Ordinary Shares subject to award
Ed Barker - Chief Financial Officer 42,217
Simon Callander - Group General Counsel and Company Secretary 17,990
Andrea Cartwright - Group HR Director 15,929
Paula Kerrigan - Group Strategy and Transformation Director 21,082
Chris Lacey - Digital Director 15,310
Euan Sutherland - Chief Executive Officer 109,318
Nick Tatum - Global Retail Director 21,082
Thomas Vulliez - Vice President USA 20,729
Jon Wragg - Global Trading Director 22,966

The above awards were notified to the Company by each PDMR referred to above on 27 July 2018.

No consideration was paid for the grant of these awards which are structured as conditional awards.

The vesting of an award is subject to the satisfaction of the following performance conditions, measured over a performance period of three financial years of the Company ending with the 2020/2021 financial year (the "performance period"):

1.           70% of the award is based on the compound annual growth rate ("CAGR") in the Company's earnings per share ("EPS") measured over the performance period.

·               25% of the EPS-related part of the award will vest if the CAGR in the EPS is 8%, increasing on a straight-line basis to 50% vesting if the CAGR in the EPS is 10% and increasing on a straight-line basis to 100% vesting if the CAGR in the EPS is 12% or more.

2.           30% of the award is based on comparing the Company's total shareholder return ("TSR") measured over the performance period against the TSR over the performance period of each company in a bespoke group of companies ("Comparator Group").

·               25% of the TSR-related part of the award will vest if the Company's TSR is ranked at the median of the companies in the Comparator Group by reference to their TSR, increasing on a straight-line basis to 100% vesting if the Company's TSR is ranked at the upper quartile or above of the companies in the Comparator Group by reference to their TSR.

Performance against each target is assessed independently. The award will normally vest on the later of the third anniversary of grant and the determination of the performance conditions.  The awards are subject to the rules of the PSP and in particular the malus and clawback provisions set out therein.

This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1.   Ed Barker

2.   Simon Callander

3.   Andrea Cartwright

4.   Paula Kerrigan

5.   Chris Lacey

6.   Euan Sutherland

7.   Nick Tatum

8.   Thomas Vulliez

9.   Jon Wragg

2

Reason for the notification

a)

Position/status

1.   Chief Financial Officer/PDMR

2.   Group General Counsel and Company Secretary/PDMR

3.   Group HR Director/PDMR

4.   Group Strategy and Transformation Director/PDMR

5.   Digital Director/PDMR

6.   Chief Executive Officer/PDMR

7.   Global Retail Director/PDMR

8.   Vice President USA/PDMR

9.   Global Trading Director/PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Superdry Plc

b)

LEI

213800GAQMT2WL7BW361

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

ISIN: GB00B60BD277

b)

Nature of the transaction

Grant of conditional share awards under the Superdry 2018 Performance Share Plan

c)

Price(s) and volume(s)

Price(s) Volume(s)
1.   £13.324

2.   £13.324

3.   £13.324

4.   £13.324

5.   £13.324

6.   £13.324

7.   £13.324

8.   £13.324

9.   £13.324
1. 42,217

2. 17,990

3. 15,929

4. 21,082

5. 15,310

6. 109,318

7. 21,082

8. 20,729

9. 22,966

d)

Aggregated information

Price(s) Aggregated Volume(s)
1.   £562,499.31

2.   £239,698.76

3.   £212,238.00

4.   £280,896.57

5.   £203,990.44

6.   £1,456,553.03

7.   £280,896.57

8.   £276,193.20

9.   £305,998.98
1. 42,217

2. 17,990

3. 15,929

4. 21,082

5. 15,310

6. 109,318

7. 21,082

8. 20,729

9. 22,966

e)

Date of the transaction

25 July 2018

f)

Place of the transaction

London Stock Exchange (XLON)

30 July 2018

For further information:
Superdry Plc
Simon Callander

Company Secretary
+44 (0) 1242 586643

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHWGUWCMUPRGCU